CDKV Holdings’s Sanofi SNY Stock Holding History

CDKV Holdings’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$32K	Hold	750	–	–	0.03%	155
2026 Q1	$36.1K	Hold	750	–	–	0.03%	141
2025 Q4	$36.3K	Buy	+750	New	+$37.2K	0.03%	147

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

CDKV Holdings's SNY Position: Q2 2026 in Review

CDKV Holdings held its Sanofi (SNY) position steady in Q2 2026 at 750 shares worth $32K. The position accounts for 0.03% of the portfolio, ranked #155.

CDKV Holdings first reported a position in SNY in Q4 2025 and has held it in 3 quarters since. The position peaked at $36.3K in Q4 2025. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

CDKV Holdings held 750 shares of Sanofi worth $32K as of Q2 2026.
CDKV Holdings left its Sanofi share count unchanged in Q2 2026.
Sanofi made up 0.03% of CDKV Holdings's portfolio in Q2 2026, its #155 holding.
CDKV Holdings first reported a position in Sanofi in Q4 2025 and has held it in 3 quarters since.
CDKV Holdings's Sanofi position peaked at $36.3K in Q4 2025.
714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on CDKV Holdings's 13F filing for Q2 2026, filed 31 Jul 2026.